The Company Brain and the Future of Go-to-Market Strategy

The key mechanism is not “AI adoption” but ROI verification. If teams are buying agents faster than they can prove incremental pipeline, budget owners will reclassify these tools from growth levers to discretionary software spend, which typically hits renewal rates before it shows up in headline usage. That creates a 1-3 month setup where point solutions tied to SDR productivity and lead-gen are most vulnerable, while large platforms with bundled AI can mask weaker standalone demand through suite pricing.

Second-order, this is a classic consolidation regime: when the workflow outcome is flat, buyers stop tolerating fragmented stacks and gravitate to the system of record. That is structurally better for CRM and Microsoft’s embedded copilots than for smaller GTM vendors like HUBS, ZI, BRZE, or FIVN, whose AI features are easier to commoditize. The bigger hidden loser may be services and outsourced sales/BPO providers, because the promised labor arbitrage is not yet translating into measurable throughput.

Contrarian view: the market may be underestimating the lag between usage and conversion. Agent adoption can still be economically rational even with flat pipelines today if the compounding benefit shows up in six to eighteen months via lower CAC and faster rep ramp, so the selloff in software could be premature. What would falsify the bearish read is a next-quarter improvement in win rates, SQL-to-opportunity conversion, or net retention at GTM vendors; absent that, this looks like a proof-of-value problem, not a demand-cycle rebound.